Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.38 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | AURKA | O14965 | 1/20 | 0.36 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.36 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.36 |
| ▸ | RET | P07949 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28804419 | 0.81 | HSD17B10 (0.44) | GABRA1GABRB2MTNR1AALDH1A1HSD17B10 | |
| SCHEMBL728402 | 0.80 | KMT2A (0.47) | GABRA1GABRB2MTNR1AALDH1A1HSD17B10 | |
| SCHEMBL8724008 | 0.78 | ALDH1A1 (0.43) | GABRA1GABRB2MTNR1AALDH1A1HSD17B10 | |
| SCHEMBL10337992 | 0.78 | ALDH1A1 (0.40) | GABRA1GABRB2ALDH1A1HPGDGAA | |
| SCHEMBL729571 | 0.77 | ALDH1A1 (0.47) | GABRA1GABRB2MTNR1AALDH1A1HSD17B10 | |
| SCHEMBL12827498 | 0.76 | GABRA1 (0.42) | GABRA1GABRB2AKR1B1MTNR1AALDH1A1 | |
| SCHEMBL27930641 | 0.76 | ALDH1A1 (0.55) | GABRA1GABRB2MTNR1AALDH1A1HSD17B10 | |
| SCHEMBL28831011 | 0.76 | ALDH1A1 (0.45) | GABRA1GABRB2MTNR1AALDH1A1HSD17B10 | |
| SCHEMBL4338851 | 0.75 | MEN1 (0.37) | GABRA1GABRB2SRD5A1ALDH1A1HSD17B10 | |
| SCHEMBL1685061 | 0.75 | GABRA1 (0.45) | GABRA1GABRB2AKR1B1SRD5A1MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0892774-A4 | PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO | ANADYS PHARMACEUTICALS INC (US) | 2001-10-04 | — | — | EP | disclosed |
| US-6239291-B1 | Pyronin antibacterials, process and novel intermediates thereto | SCRIPTGEN PHARMACEUTICALS, INC. | 2001-05-29 | — | — | US | disclosed |
| US-6228882-B1 | MYXOPYRONINS AND CORALLOPYRONINS; RNA POLYMERASE INHIBITORS; SAPONIFICATION, ACIDIFICATION, AZIDING, ACYLATION | ANADYS PHARMACEUTICALS, INC. | 2001-05-08 | — | — | US | disclosed |
| US-6191288-B1 | Pyronin antibacterials, process and novel intermediates thereto | ANADYS PHARMACEUTICALS, INC. | 2001-02-20 | — | — | US | disclosed |
| US-6184393-B1 | MYXOPYRONINS AND CORALLOPYRONINS AS FURAN AND PYRAN- AND SMALL LACTONE-ANTIBIOTICS; INHIBITORS OF RNA POLYMERASE (RNAP) HAVING SELECTIVITY FOR HUMAN RNAP, CELL PENETRATION AND POTENCY AGAINST RIFAMPICIN-RESISTANT STAPH. AUREUS | TRUSTEES OF BOSTON UNIVERSITY | 2001-02-06 | — | — | US | disclosed |
| EP-1043990-A1 | PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO | Scriptgen Pharmaceuticals, Inc. (US) | 2000-10-18 | — | — | EP | disclosed |
| US-6127551-A | 4-HYDROXY-6-ETHYOXYCARBONYLALKENYL-2H-PYRAN-2-ONE IS ACYLATED WITH PROPIONYL CHLORIDE TO FORM A KETONE ADDUCT, FOLLOWED BY BASE-CATALYZED ALDOL TO FROM A PYRONE ALDOL; MESYLATION, FORM A PYRONE KETONE; AND CURTIUS SEQUENCE TO FORM MYXOPYRONIN | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 2000-10-03 | — | — | US | disclosed |
| US-6090953-A | PREPARING A MYXOPYRONIN | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 2000-07-18 | — | — | US | disclosed |
| WO-2000015626-A1 | PROCESS FOR THE PREPARATION OF INTERMEDIATES FOR PYRONIN ANTIBACTERIALS | ANADYS PHARMACEUTICALS, INC. (US) | 2000-03-23 | — | — | WO | disclosed |
| US-6022983-A | PREPARING A MYXOPYRONIN | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 2000-02-08 | — | — | US | disclosed |
| WO-1997034569-A2 | PYRONIN ANTIBACTERIALS, PROCESS AND INTERMEDIATES | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1997-09-25 | — | — | WO | disclosed |
| EP-0173050-B1 | SELECTED 2,2,6,6-TETRAMETHYL-4-PIPERIDINYL DERIVATIVES AND THEIR USE AS LIGHT STABILIZERS | OLIN CORPORATION (US) | 1991-11-13 | — | — | EP | disclosed |
| EP-0365539-A4 | HUMAN LEUCOCYTE ELASTASE INHIBITOR COMPOUNDS | — | 1990-12-05 | — | — | EP | disclosed |
| EP-0147211-B1 | 4H-3,1-BENZOXAZIN-4-ONES AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION | SYNTEX (U.S.A.) INC. (US) | 1990-09-12 | — | — | EP | disclosed |
| EP-0365539-A1 | HUMAN LEUCOCYTE ELASTASE INHIBITOR COMPOUNDS | AUSTRALIAN COMMERCIAL RESEARCH & DEVELOPMENT LIMITED (AU) | 1990-05-02 | — | — | EP | disclosed |
| WO-1988010258-A1 | HUMAN LEUCOCYTE ELASTASE INHIBITOR COMPOUNDS | LA TROBE UNIVERSITY (AU) | 1988-12-29 | — | — | WO | disclosed |
| US-4657893-A | ANTIINFLAMMATORY AGENTS | SYNTEX (U.S.A.) INC. (US) | 1987-04-14 | — | — | US | disclosed |
| EP-0173050-A2 | Selected 2,2,6,6-tetramethyl-4-piperidinyl derivatives and their use as light stabilizers | OLIN CORPORATION (US) | 1986-03-05 | — | — | EP | disclosed |
| US-4548973-A | SUNSCREENS | OLIN CORPORATION (US) | 1985-10-22 | — | — | US | disclosed |
| EP-0147211-A2 | 4H-3,1-benzoxazin-4-ones and related compounds, pharmaceutical compositions containing them, and processes for their preparation | SYNTEX (U.S.A.) INC. (US) | 1985-07-03 | — | — | EP | disclosed |